WNT9A and malignant colon neoplasm: Furthermore, hypermethylation and the resultant low expression of Wnt9a occur frequently in primary colon cancer and corresponding cell lines (57), suggesting that activating the Wnt9a-mediated pathway may have a therapeutic effect on colorectal cancer.